Pfenex Inc (PFNX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

10790 ROSELLE STREET SAN DIEGO, CA 92121

Pfenex Inc. provides clinical-stage biotechnology products. The Company offers high-value proteins and biosimilar therapeutics.

Data as of 2020-05-24
Market Cap235.585 Million Shares Outstanding34.292 Million Avg 30-day Volume436.54 Thousand
P/E Ratio Dividend Yield EPS-0.17
Price/Sales5.796 Price cash flow ratio7.5 Price free cash flow ratio-45.2
Book Value2.43 Price to Tangible Book3.18 Alpha-0.01
Short Interest Ratio2.04 % Short Interest to Float2.6 R-squared0.0392
BETA0.860214 52-week High/Low14.0 / 5.26 Stddev0.18451
View SEC Filings from PFNX instead.

View recent insider trading info

Funds Holding PFNX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PFNX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SCHNEIDER PHILLIP M

  • Director
0 2020-05-08 1

CAMPBELL ROBIN

  • Director
0 2020-05-08 1

TAYLOR JOHN MACK

  • Director
0 2020-05-08 1

GRENFELL-GARDNER JASON

  • Director
0 2020-05-08 1

MARQUET MAGDA

  • Director
0 2020-05-08 1

MASUOKA LORIANNE

  • Director
0 2020-05-08 3

LUCY PATRICK K. CHIEF BUSINESS OFFICER

  • Officer
90,246 2020-03-02 5

FENTON DENNIS M

  • Director
0 2020-02-12 0

SCHIMMELPENNINK EVERT B. SEE REMARKS

  • Officer
  • Director
0 2020-02-03 1

SCRANTON SHAWN CHIEF OPERATING OFFICER

  • Officer
0 2020-02-03 1

BRENNER MARTIN CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-02-03 1

GALE JAMES C

  • Director
0 2020-01-02 0

OLAFSSON SIGURDUR O

  • Director
0 2019-05-09 0

KNUDSON SUSAN A. CHIEF FINANCIAL OFFICER

  • Officer
0 2019-02-01 0

LADY PATRICIA CHIEF ACCOUNTING OFFICER

  • Officer
0 2018-02-01 0

CHEN HUBERT C SEE REMARKS

  • Officer
0 2018-02-01 0

DOW CHEMICAL CO /DE/

  • 10% Owner
17,710,393 2017-08-30 0

WAGNER PAUL A. CHIEF FINANCIAL OFFICER

  • Officer
0 2017-03-01 0

SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP

  • 10% Owner
556,656 2017-01-06 0

SANDOVAL STEVEN S. SR. CHIEF MANUFACTURING OFFICER

  • Officer
0 2016-10-03 0

ROHN WILLIAM R

  • Director
No longer subject to file 2016-07-27 0

TALBOT HENRY W. JR. VP OF OPERATIONS

  • Officer
0 2016-02-01 0

LIANG BERTRAND C. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2016-02-01 0

SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP

SIGNET HEALTHCARE PARTNERS QP PARTNERSHIP II LP

  • 10% Owner
3,395,147 2014-07-29 0

VAN HEEL KENNETH

  • Director
0 2014-07-17 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

TAYLOR JOHN MACK - Director

2020-05-08 A 18,000 a 18,000 0.00 direct

MARQUET MAGDA - Director

2020-05-08 A 18,000 a 18,000 0.00 direct

GRENFELL-GARDNER JASON - Director

2020-05-08 A 18,000 a 18,000 0.00 direct

MASUOKA LORIANNE - Director

2020-05-08 A 18,000 a 18,000 0.00 direct

SCHNEIDER PHILLIP M - Director

2020-05-08 A 18,000 a 18,000 0.00 direct

CAMPBELL ROBIN - Director

2020-05-08 A 18,000 a 18,000 0.00 direct

Elevate your investments